Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
99 Leser
Artikel bewerten:
(0)

Capita Powers National Healthcare Advice Line in Australia

BASINGSTOKE, England, January 13, 2016 /PRNewswire/ --

Capita Healthcare Decisions' TeleGuides clinical content set and Decision Management System (DMS) is now powering a national telephone triage service which offers health advice to thousands of Australians each month.

The telephone triage service is managed by Healthdirect Australia, established by the Council of Australian Governments to deliver a range of services to offer every Australian 24/7 access to trusted health advice.

(Logo: http://photos.prnewswire.com/prnh/20150402/736790 )

Healthdirect Australia contracted Medibank - a national provider of healthcare solutions and health insurance services in Australia - to deliver and operate the telephone triage service. Capita was selected for its decision support software and clinical content. Capita has worked closely with Medibank to localise the clinical content set specifically for the Australian market.

DMS helps clinicians make decisions regarding the next steps of care required for the patient by taking them through a sophisticated decision pathway process based on the answers given to symptom based questions. According to the answers given, and other information that may already be known, the clinician suggests appropriate next steps. Information gathering and direction to the next stage of care is quick and consistent, making the patient journey faster, safer and better.

As part of this project, Capita's DMS software was integrated with a third party Customer Relationship Management (CRM) system. DMS has an open Application Programming Interface (API) allowing integration with a range of other technologies including Microsoft and SAP. Medibank is also using DMS and TeleGuides for a range of other clients in Australia who require 24x7 health advice from registered nurses and GPs.

Since July 2015, the software and content have enabled clinicians to deliver safe, consistent telephone triage to more than 2,000 callers every day. The majority of callers (52%) are ringing to discuss their own symptoms, while a third of callers are mothers ringing up about their child, with 29% of such calls relating to children aged 0-4.

Dermot Roche, Medibank's General Manager of Telephone, Online & Population Health said: "The partnership with Capita has already proved to be a great success - the feedback we have had from clinicians using the system has been excellent. The fact that the software can be deployed in market leading CRM systems means there has been lots of interest from our clients throughout Australia. Importantly, we have deployed the integrated CRM and clinical decision support system to over 500 clinical staff who work from their homes, operate 24x7 and ensure that over 80% of calls are answered within 20 seconds, delivering both a clinically safe a very satisfying patient experience."

Maureen Robinson, General Manager of Clinical Governance for Healthdirect Australia talks about the service: "Capita's software enables clinicians handling calls to quickly and safely triage the patient - and direct them to the next stage of care. More than 2000 people a day are using the service and being directed to the most appropriate health service based on the severity and urgency of their health issue"

Richard Atkins, General Manager, International for Capita said: "Our TeleGuides clinical content set has been through a robust governance process and the experience of nearly 90million patient encounters worldwide without clinical incident. We are delighted that the software is already benefiting the population of Australia and helping thousands of people receive safe, timely, accurate healthcare advice."

Note to editors:

About Capita Healthcare Decisions

We transform healthcare decision making. Our solutions support healthcare providers to make better decisions about their patients, and empower individuals to make better decisions about their own health and wellbeing. Over the past 16 years, our decision support software applications have been used by some of the world's leading healthcare providers and insurers to power over 85m patient transactions. Capita Healthcare Decisions brings together clinical expertise and Silicon Valley innovation to power decision support which delivers more for less and is underpinned by three principles: safe, connected, useful. For more information go to http://www.capitahealthcaredecisions.com

Capita is a leading UK provider of technology-enabled customer and business process services and integrated professional support services. With 74,000 people at over 400 sites, including 80 business centres across the UK, Europe, India and South Africa, Capita uses its expertise, infrastructure and scale benefits to transform its clients' services, driving down costs and adding value. Capita is quoted on the London Stock Exchange (CPI.L), and is a constituent of the FTSE 100 with 2014 revenue of £4.4 billion. Further information on Capita can be found at: http://www.capita.co.uk.

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.